Biotherapeutics News and Research

RSS
Berkeley Lights announces Opto™ antigen-presenting bead kit to accelerate the expansion of antigen-specific T cells used to develop cell-based therapies

Berkeley Lights announces Opto™ antigen-presenting bead kit to accelerate the expansion of antigen-specific T cells used to develop cell-based therapies

Avacta provides update on COVID-19 rapid antigen test development partnership with Cytiva

Avacta provides update on COVID-19 rapid antigen test development partnership with Cytiva

Human trials to commence using SARS-CoV-2 antibodies from cow's blood

Human trials to commence using SARS-CoV-2 antibodies from cow's blood

Avacta provides update on Affimer therapy for COVID-19 infection

Avacta provides update on Affimer therapy for COVID-19 infection

C-Path's Transplant Therapeutics Consortium receives positive FDA response for its Letter of Intent

C-Path's Transplant Therapeutics Consortium receives positive FDA response for its Letter of Intent

Scientists find potential new way to improve treatment for Von Willebrand Disease

Scientists find potential new way to improve treatment for Von Willebrand Disease

Avacta provides update on COVID-19 antigen diagnostic test development with Adeptrix

Avacta provides update on COVID-19 antigen diagnostic test development with Adeptrix

CSL Behring and Seattle Children's partner to develop gene therapies for primary immunodeficiency diseases

CSL Behring and Seattle Children's partner to develop gene therapies for primary immunodeficiency diseases

New Thermo Scientific Proteome Discoverer 2.5 software strengthens laboratory workflows

New Thermo Scientific Proteome Discoverer 2.5 software strengthens laboratory workflows

New high-resolution mass spectrometer expands the proven Thermo Scientific Orbitrap platform

New high-resolution mass spectrometer expands the proven Thermo Scientific Orbitrap platform

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test

Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test

Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins

Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix

Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

Avacta partners with Cytiva to develop a rapid test for COVID-19

Avacta partners with Cytiva to develop a rapid test for COVID-19

Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors

Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors

Isolating Single T-cells of Interest using an Optofluidic Platform

Isolating Single T-cells of Interest using an Optofluidic Platform